Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Endocyte
Endocyte
Novartis Is Looking for Deals. Are These 3 Biotechs on Its List?
Motley Fool
Mon, 05/2/22 - 11:57 am
Novartis
M&A
AveXis
Zolgensma
Endocyte
Pluvicto
The Medicines Company
Levqio
Endocyte deal showcases Novartis' complex manufacturing juggling act
Biopharma Dive
Thu, 10/25/18 - 11:25 pm
Novartis
Endocyte
earnings
drug manufacturing
Crazy biotech: Endocyte reaches 2-billion value over few months
GoinPharma
Sun, 10/21/18 - 11:34 pm
Endocyte
Novartis buys Endocyte for $2.1B in latest deal under CEO Narasimhan
Biopharma Dive
Thu, 10/18/18 - 01:08 pm
Novartis
earnings
M&A
Endocyte
Pharma/Biotech Stocks to Watch This Prostate Cancer Month
Yahoo/Zacks.com
Sun, 09/16/18 - 02:16 pm
prostate cancer
JNJ
Zytiga
Erleada
Pfizer
Astellas
Xtandi
AbbVie
Lupron
Endocyte
Lu-PSMA-617
With clear regulatory path, Endocyte raises $175M
BioCentury
Tue, 09/11/18 - 11:29 pm
Endocyte
177Lu-PSMA-617
The 4 Best Biotech Stocks of 2018 (So Far)
Motley Fool
Sat, 07/14/18 - 01:22 pm
biotech
Arrowhead Research
Endocyte
Arqule
Madrigal Pharmaceuticals
3 Huge Biotech Winners in 2018 (So Far)
Motley Fool
Wed, 07/11/18 - 10:17 am
biotech
Arrowhead Pharmaceuticals
Endocyte
Madrigal Pharmaceuticals
4 Biotech Stocks That Tripled in the First Half of 2018
Motley Fool
Mon, 07/2/18 - 10:17 pm
biotech
biotech stocks
Arrowhead Pharmaceuticals
Arqule
Endocyte
Madrigal Pharmaceuticals
The 3 Best Biotech Stocks of 2018 So Far
Motley Fool
Sat, 06/30/18 - 11:52 am
Innovate Biopharmaceuticals
Arrowhead Pharmaceuticals
Endocyte
The Week Ahead In Biotech: ASCO Presentations In The Spotlight
Yahoo/Benzinga
Mon, 05/28/18 - 02:14 pm
ASCO 2018
European Society of Cardiology
TherapeuticsMD
Abiomed
Incyte
Bluebird Bio
Celgene
Syndax
Loxo Oncology
Exelixis
Karyopharm
Endocyte
Celldex Therapeutics
Jounce Therapeutics
Bristol-Myers Squibb
Nektar
Winners and Losers From the Biggest Cancer Meeting of the Year (So Far)
Motley Fool
Fri, 05/18/18 - 10:00 pm
ASCO
Endocyte
Loxo Oncology
Blueprint Medicines
Nektar Therapeutics
Jounce Therapeutics
3 Drug Stocks That Soared This Week
Motley Fool
Sun, 10/8/17 - 11:26 am
Endocyte
PSMA-617
MannKind
Afrezza
Mylan Labs
generics
Teva Pharmaceutical
Prescribed Reading: DMD, MS and other acronyms
Biopharma Dive
Sun, 10/8/17 - 11:22 am
Celgene
Nimbus
Endocyte
Amicus Therapeutics
Catabasis
Motif Biosciences
Endocyte Adds Phase 3-Ready Prostate Cancer Drug with ABX Deal
Xconomy
Mon, 10/2/17 - 11:07 am
Endocyte
prostate cancer
ABX
PSMA-617
Endocyte slumps on staff and R&D cuts
BioPharma Dive
Wed, 06/7/17 - 10:06 am
Endocyte
layoffs
R&D
Endocyte slashes staff and retrenches in the wake of back-to-back R&D setbacks
Endpoints
Fri, 06/2/17 - 10:42 am
Endocyte
layoffs
R&D
EC1456
Endocyte reports first-quarter loss but meets expectations
Yahoo/AP
Wed, 05/4/16 - 08:53 am
Endocyte
earnings
Endocyte Announces Final Overall Survival Results From Phase 2b TARGET Trial in Non-Small Cell Lung Cancer Patients
Yahoo
Tue, 09/8/15 - 08:08 am
Endocyte
vintafolide
clinical trials
non-small cell lung cancer
Should Endocyte abandon a cancer drug that works?
Indianapolis Business Journal, IN
Tue, 09/30/14 - 12:44 pm
Endocyte
vintafolide
lung cancer
Pages
1
2
3
4
next ›
last »